Abstract

The gastric bacterium Helicobacter pylori causes a persistent infection that is directly responsible for gastric ulcers and gastric cancer in some patients and protective against allergic and other immunological disorders in others. The two outcomes of the Helicobacter-host interaction can be modeled in mice that are infected as immunocompetent adults and as neonates, respectively. Here, we have investigated the contribution of the Helicobacter immunomodulator VacA to H. pylori-specific local and systemic immune responses in both models. We found that neonatally infected mice are colonized at higher levels than mice infected as adults and fail to generate effector T-cell responses to the bacteria; rather, T-cell responses in neonatally infected mice are skewed toward Foxp3-positive (Foxp3+) regulatory T cells that are neuropilin negative and express RORγt. We found these peripherally induced regulatory T cells (pTregs) to be enriched, in a VacA-dependent manner, not only in the gastric mucosa but also in the lungs of infected mice. Pulmonary pTreg accumulation was observed in mice that have been infected neonatally with wild-type H. pylori but not in mice that have been infected as adults or mice infected with a VacA null mutant. Finally, we traced VacA to gastric lamina propria myeloid cells and show that it suppressed interleukin-23 (IL-23) expression by dendritic cells and induced IL-10 and TGF-β expression in macrophages. Taken together, the results are consistent with the idea that H. pylori creates a tolerogenic environment through its immunomodulator VacA, which skews T-cell responses toward Tregs, favors H. pylori persistence, and affects immunity at distant sites.IMPORTANCEHelicobacter pylori has coexisted with humans for at least 60.000 years and has evolved persistence strategies that allow it to evade host immunity and colonize its host for life. The VacA protein is expressed by all H. pylori strains and is required for high-level persistent infection in experimental mouse models. Here, we show that VacA targets myeloid cells in the gastric mucosa to create a tolerogenic environment that facilitates regulatory T-cell differentiation, while suppressing effector T-cell priming and functionality. Tregs that are induced in the periphery during H. pylori infection can be found not only in the stomach but also in the lungs of infected mice, where they are likely to affect immune responses to allergens.

Highlights

  • IMPORTANCE Helicobacter pylori has coexisted with humans for at least 60.000 years and has evolved persistence strategies that allow it to evade host immunity and colonize its host for life

  • To investigate in more detail whether vacuolating cytotoxin (VacA) proficiency and the age of the mice at the time of infection affect gastric T-cell responses, we conducted a multicolor flow cytometric analysis of gastric lamina propria (LP) T-cell populations of mice that had been infected at 7 days or 6 weeks of age with wild-type H. pylori or its isogenic VacA-deficient mutant

  • Whereas neonatally infected mice were characterized by high-level colonization but no detectable CD4ϩ T-cell infiltration, their counterparts that had been infected as immunocompetent adults were colonized at lower levels and showed strong CD4ϩ T-cell recruitment (Fig. 1A and B; see Fig. S1A in the supplemental material)

Read more

Summary

Introduction

IMPORTANCE Helicobacter pylori has coexisted with humans for at least 60.000 years and has evolved persistence strategies that allow it to evade host immunity and colonize its host for life. VacA Interacts with Myeloid Cells and Promotes Tregs of mice with H. pylori strains deficient in either of the two immunomodulators is associated with improved immune control and clearance [24,25,26] and with a reduced capability of DCs to prime Treg differentiation in the periphery, relative to infection of mice with wild-type (WT) H. pylori strains Both gGT and VacA can be used in purified or recombinant form to reduce the severity of allergy symptoms in prophylactic settings, provided that the proteins are administered early in life [27]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.